Tantech Holdings Ltd (NASDAQ:TANH) (“Tantech” or the “Company”), a clean energy company, today announced it received notification from The Nasdaq Stock Market LLC (“Nasdaq”) confirming the Company has regained compliance with the periodic filing requirement for Nasdaq under Listing Rule 5250(c)(1). Nasdaq noted this matter is now closed.
Cadrenal Therapeutics Highlights Additional Need For A New Vitamin K Antagonist Following Updates From The Recent European Society Of Cardiology Congress
Tecarfarin is the only known Novel Vitamin K Antagonist in Development
PONTE VEDRA, Fla., Sept. 5, 2023 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (NASDAQ:CVKD) a biopharmaceutical
